- Home
- TTD vs IQV Comparison
TTD vs IQV Comparison
Compare TTD & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTD
- IQV
- Stock Information
- Founded
- TTD 2009
- IQV 1982
- Country
- TTD United States
- IQV United States
- Employees
- TTD N/A
- IQV N/A
- Industry
- TTD Computer Software: Programming Data Processing
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TTD Technology
- IQV Health Care
- Exchange
- TTD Nasdaq
- IQV Nasdaq
- Market Cap
- TTD 23.4B
- IQV 26.7B
- IPO Year
- TTD 2016
- IQV 2013
- Fundamental
- Price
- TTD $75.22
- IQV $140.26
- Analyst Decision
- TTD Buy
- IQV Buy
- Analyst Count
- TTD 34
- IQV 20
- Target Price
- TTD $102.30
- IQV $226.80
- AVG Volume (30 Days)
- TTD 12.0M
- IQV 2.7M
- Earning Date
- TTD 05-08-2025
- IQV 05-06-2025
- Dividend Yield
- TTD N/A
- IQV N/A
- EPS Growth
- TTD 104.63
- IQV 0.26
- EPS
- TTD 0.82
- IQV 7.35
- Revenue
- TTD $2,569,599,000.00
- IQV $15,497,000,000.00
- Revenue This Year
- TTD $17.96
- IQV $5.40
- Revenue Next Year
- TTD $18.38
- IQV $5.21
- P/E Ratio
- TTD $91.88
- IQV $19.10
- Revenue Growth
- TTD 25.07
- IQV 2.84
- 52 Week Low
- TTD $42.96
- IQV $134.65
- 52 Week High
- TTD $141.53
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- TTD 63.78
- IQV 42.30
- Support Level
- TTD $71.85
- IQV $134.65
- Resistance Level
- TTD $78.03
- IQV $141.67
- Average True Range (ATR)
- TTD 2.50
- IQV 4.63
- MACD
- TTD -0.25
- IQV 0.21
- Stochastic Oscillator
- TTD 38.74
- IQV 25.64
About TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.